BIOLEN

Serial Number 88595213
Registration 6323243
700

Registration Progress

Application Filed
Aug 27, 2019
Under Examination
Mar 3, 2020
Approved for Publication
Jan 7, 2020
Published for Opposition
Jan 7, 2020
Registered
Apr 13, 2021

Trademark Image

BIOLEN

Basic Information

Serial Number
88595213
Registration Number
6323243
Filing Date
August 27, 2019
Registration Date
April 13, 2021
Published for Opposition
January 7, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 13, 2021
Registration
Registered
Classes
010

Rights Holder

Alessa Therapeutics, Inc.

03
Address
930 Brittan Avenue
San Carlos, CA 94070

Ownership History

Alessa Therapeutics, Inc.

Original Applicant
03
San Francisco, CA

Alessa Therapeutics, Inc.

Owner at Publication
03
San Carlos, CA

Alessa Therapeutics, Inc.

Original Registrant
03
San Carlos, CA

Legal Representation

Attorney
John L. Slafsky

USPTO Deadlines

Next Deadline
470 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210413)
Due Date
April 13, 2027
Grace Period Ends
October 13, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Apr 13, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 11, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 10, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 17, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 1, 2021 IUAF S USE AMENDMENT FILED Loading...
Feb 17, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 1, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 16, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 1, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 30, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 30, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 3, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 5, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 27, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 10, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 30, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Medical device for drug delivery to solid organ tumors; medical device for delivery of anti-androgen drugs to prostate tissue; medical device for treating cancer; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems
First Use Anywhere: 20201000
First Use in Commerce: 20201000

Additional Information

Pseudo Mark
BIO LEN

Classification

International Classes
010